<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1995
Commission File No. 0-27640
RENAL CARE GROUP, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
Delaware 62-1622383
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
</TABLE>
1801 West End Ave., Suite 1100, Nashville, Tennessee 37203
(Address of principal executive offices)
(615) 321-2333
Securities registered pursuant to Section 12(b) of the Act:
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 Par Value
(Title of class)
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No .
--- ---
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]
The aggregate market value of common stock, par value $.01 per share (the
"Common Stock") held by non-affiliates, based upon the closing sales price, was
approximately $82,552,000 as of May 10, 1996. In the determination of this
amount, affiliates include all of the Company's officers, directors, and
persons known to the Company to be beneficial owners of more than five percent
of the Company's Common Stock. This amount should not be deemed conclusive for
any other purpose. As of May 10, 1996, a total of 9,857,000 shares of the
Company's Common Stock were outstanding.
<PAGE> 2
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1995
Commission File No. 0-27640
RENAL CARE GROUP, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
Delaware 62-1622383
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
</TABLE>
1801 West End Ave., Suite 1100, Nashville, Tennessee 37203
(Address of principal executive offices)
(615) 321-2333
Securities registered pursuant to Section 12(b) of the Act:
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 Par Value
(Title of class)
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No .
--- ---
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]
The aggregate market value of common stock, par value $.01 per share (the
"Common Stock") held by non-affiliates, based upon the closing sales price, was
approximately $82,552,000 as of May 10, 1996. In the determination of this
amount, affiliates include all of the Company's officers, directors, and
persons known to the Company to be beneficial owners of more than five percent
of the Company's Common Stock. This amount should not be deemed conclusive for
any other purpose. As of May 10, 1996, a total of 9,857,000 shares of the
Company's Common Stock were outstanding.
<PAGE> 3
Renal Care Group, Inc. (the "Company") hereby amends the following items
on Form 10-K of the fiscal year ended January 31, 1996 (the "Form 10-K") of its
predecessor, Kidney Care, Inc., as set forth on the pages hereto:
1. Cover page of the Form 10-K
2. Signatures
<PAGE> 4
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized on May 21, 1996.
RENAL CARE GROUP, INC.
By: /s/ RONALD HINDS
-------------------------------
Ronald Hinds
Executive Vice President,
Chief Financial Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed by the following persons in the capacities indicated.
<TABLE>
<CAPTION>
Signature Title
--------- -----
<S> <C>
/s/ HARRY R. JACOBSON, M.D. Chairman of the Board
- -------------------------------------
Harry R. Jacobson, M.D.
/s/ SAM A. BROOKS President, Chief Executive Officer
- ------------------------------------- and Director
Sam A. Brooks
/s/ JOHN D. BOWER, M.D. Vice Chairman of the Board
- -------------------------------------
John D. Bower, M.D.
/s/ JOSEPH C. HUTTS Director
- -------------------------------------
Joseph C. Hutts
/s/ THOMAS LOWERY, M.D. Director
- -------------------------------------
Thomas Lowery, M.D.
/s/ STEPHEN D. MCMURRAY, M.D. Director
- -------------------------------------
Stephen D. McMurray, M.D.
/s/ W. TOM MEREDITH, M.D. Director
- -------------------------------------
W. Tom Meredith, M.D.
</TABLE>
<PAGE> 5
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized on June 7, 1996.
RENAL CARE GROUP, INC.
By: /s/ RONALD HINDS
-------------------------------
Ronald Hinds
Executive Vice President,
Chief Financial Officer
